CLC (ARGX-118 Biosimilar) Recombinant Monoclonal Antibody

Code CSB-RA2267MB1HU
Size US$9799
Order now
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No.
Target Names
Alternative Names
CLC antibody; LGALS10 antibody; LGALS10A antibody; Galectin-10 antibody; Gal-10 antibody; Charcot-Leyden crystal protein antibody; CLC antibody; Eosinophil lysophospholipase antibody; Lysolecithin acylhydrolase antibody
Species Reactivity
Human
Immunogen
Recombinant Human CLC protein
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated
Clonality
Monoclonal
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
0.01M PBS,pH7.4
Form
Liquid
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Notes
Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity > 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method.
Lead Time
3-4 weeks
Description

This recombinant monoclonal antibody is designed as a research-grade biosimilar to ARGX-118, targeting the Charcot-Leyden crystal (CLC) protein, also known as galectin-10. CLC is predominantly expressed in eosinophils and basophils, where it constitutes a significant portion of cellular protein content. Upon degranulation of these cells, CLC is released into tissues and can crystallize, forming characteristic bipyramidal crystals that serve as hallmarks of eosinophilic inflammation. This protein plays a crucial role in type 2 inflammatory responses and has been implicated in various allergic and eosinophilic disorders, including asthma, chronic rhinosinusitis, eosinophilic esophagitis, and hypereosinophilic syndromes.

ARGX-118 represents a therapeutic antibody approach aimed at neutralizing CLC to modulate eosinophil-driven inflammation. As a research-grade biosimilar, this antibody provides investigators with a valuable tool for studying CLC biology, eosinophil function, and the pathophysiology of type 2 inflammatory diseases. It supports investigations into novel therapeutic strategies for conditions characterized by aberrant eosinophil activation and tissue infiltration.

Usage
It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Regulates immune responses through the recognition of cell-surface glycans. Essential for the anergy and suppressive function of CD25-positive regulatory T-cells (Treg).
Gene References into Functions
  1. findings show that galectin-10 functions as a T cell-suppressive molecule in eosinophils PMID: 28515279
  2. The results support the potential for galectin-10 to be used as a surrogate biomarker of eosinophilic airway inflammation. PMID: 22880030
  3. CLC and IFNAR1 were identified to be overall differentially expressed between early- and late-onset CRC, and are important in the development of early-onset CRC. PMID: 21716316
  4. DK-PGD-induced CLC/Gal-10 mRNA level can serve as a potential marker for monitoring pharmacodynamic effects of blood exposure to CRTH2 modulating agents PMID: 20858065
  5. Genetic variation in Charcot-Leyden crystal protein was found to be associated with allergic rhinitis PMID: 19650845
  6. downregulated significantly in acute myeloid leukemia patients whose white blood cell count was higher than 100 x 10(9)/L cells PMID: 12031912
  7. Changes in the expressions of galectin-10 are potentially important for myeloid cell differentiation into specific lineages. PMID: 12714580
  8. The five genes, and three of the encoded proteins, were shown differentially expressed between a group of keratoconus patients and a reference group using different techniques PMID: 16015083
  9. Downregulated in whole blood of infants hospitalised with respiratory syncytial virus (RSV), subtype B, bronchiolitis. PMID: 17166282
  10. expressed in human T lymphocytes, galectin-10 is essential for the functional properties of CD25(+) Treg cells. PMID: 17502455
  11. Data show that galectin-10 expression was related to the histological grade and with the number of eosinophils in the lesion. PMID: 19758173

Show More

Hide All

Subcellular Location
Cytoplasm, cytosol. Cytoplasmic granule. Note=Localized in granules from where it may be secreted or transported to other locations in the cell.
Tissue Specificity
Expressed abundantly in the bone marrow. Expressed exclusively by eosinophils and basophils. Not detected in monocytes and neutrophils. Expressed in CD25-positive regulatory T-cells (Treg) (at protein level). Found in intestinal tissue from patients with
Database Links

HGNC: 2014

OMIM: 153310

KEGG: hsa:1178

STRING: 9606.ENSP00000221804

UniGene: Hs.889

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2026 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*